
Ventas (VTR) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
1.4B
Gross Profit
572.4M
42.15%
Operating Income
197.7M
14.56%
Net Income
48.4M
3.56%
EPS (Diluted)
$0.10
Balance Sheet Metrics
Total Assets
26.2B
Total Liabilities
15.4B
Shareholders Equity
10.8B
Debt to Equity
1.42
Cash Flow Metrics
Operating Cash Flow
352.0M
Free Cash Flow
203.4M
Revenue & Profitability Trend
Ventas Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 4.9B | 4.5B | 4.1B | 3.8B | 3.8B |
Cost of Goods Sold | 2.8B | 2.6B | 2.3B | 2.1B | 1.9B |
Gross Profit | 2.1B | 1.9B | 1.8B | 1.7B | 1.9B |
Gross Margin % | 42.6% | 43.1% | 44.7% | 45.4% | 48.9% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 163.0M | 148.9M | 144.9M | 129.8M | 130.2M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 163.0M | 148.9M | 144.9M | 129.8M | 130.2M |
Operating Income | 681.2M | 415.5M | 483.8M | 421.4M | 591.4M |
Operating Margin % | 13.8% | 9.2% | 11.7% | 11.0% | 15.6% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 602.8M | 574.1M | 467.6M | 440.1M | 469.5M |
Other Non-Operating Income | -27.8M | 118.8M | -74.1M | 80.0M | 222.8M |
Pre-tax Income | 50.6M | -39.8M | -57.9M | 61.4M | 344.7M |
Income Tax | -37.8M | -9.5M | -16.9M | 4.8M | -96.5M |
Effective Tax Rate % | -74.7% | 0.0% | 0.0% | 7.9% | -28.0% |
Net Income | 88.4M | -30.3M | -40.9M | 56.6M | 441.2M |
Net Margin % | 1.8% | -0.7% | -1.0% | 1.5% | 11.6% |
Key Metrics | |||||
EBITDA | 1.9B | 1.9B | 1.6B | 1.6B | 1.7B |
EPS (Basic) | $0.20 | $-0.10 | $-0.12 | $0.13 | $1.18 |
EPS (Diluted) | $0.19 | $-0.10 | $-0.12 | $0.13 | $1.17 |
Basic Shares Outstanding | 411770000 | 401809000 | 399549000 | 382785000 | 373368000 |
Diluted Shares Outstanding | 411770000 | 401809000 | 399549000 | 382785000 | 373368000 |
Income Statement Trend
Ventas Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 897.8M | 508.8M | 122.6M | 149.7M | 413.3M |
Short-term Investments | - | - | - | 0 | 237.6M |
Accounts Receivable | 202.7M | 194.1M | 187.5M | 176.9M | 169.7M |
Inventory | - | - | - | - | - |
Other Current Assets | - | - | - | - | - |
Total Current Assets | 1.4B | 868.2M | 964.6M | 951.0M | 1.5B |
Non-Current Assets | |||||
Property, Plant & Equipment | - | - | - | - | - |
Goodwill | 2.1B | 2.1B | 2.1B | 2.1B | 2.1B |
Intangible Assets | 11.5M | 5.6M | 6.4M | 7.3M | 4.7M |
Long-term Investments | 40.2M | 59.3M | 23.6M | 48.9M | 50.1M |
Other Non-Current Assets | 416.5M | 319.7M | 283.1M | 250.6M | 234.4M |
Total Non-Current Assets | 24.8B | 23.9B | 23.2B | 23.8B | 22.4B |
Total Assets | 26.2B | 24.7B | 24.2B | 24.7B | 23.9B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 1.2B | 1.0B | 1.0B | 1.1B | 1.1B |
Short-term Debt | 6.4M | 14.0M | 428.2M | 336.4M | 193.5M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 2.7M | 9.2M | 6.5M | 10.8M | 3.2M |
Total Current Liabilities | 1.3B | 1.2B | 1.6B | 1.5B | 1.4B |
Non-Current Liabilities | |||||
Long-term Debt | 13.7B | 13.7B | 12.1B | 11.9B | 11.9B |
Deferred Tax Liabilities | 8.2M | 24.5M | 35.6M | 59.3M | 62.6M |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | 14.1B | 14.0B | 12.4B | 12.2B | 12.2B |
Total Liabilities | 15.4B | 15.2B | 13.9B | 13.8B | 13.7B |
Equity | |||||
Common Stock | 109.1M | 100.6M | 99.9M | 99.8M | 93.6M |
Retained Earnings | - | - | -5.4B | -4.7B | -4.0B |
Treasury Stock | 25.2M | 13.8M | 536.0K | 0 | 0 |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 10.8B | 9.5B | 10.2B | 10.9B | 10.3B |
Key Metrics | |||||
Total Debt | 13.7B | 13.7B | 12.5B | 12.2B | 12.1B |
Working Capital | 46.8M | -314.1M | -612.4M | -593.1M | 89.9M |
Balance Sheet Composition
Ventas Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 88.4M | -30.3M | -40.9M | 56.6M | 441.2M |
Depreciation & Amortization | 1.3B | 1.4B | 1.2B | 1.2B | 1.1B |
Stock-Based Compensation | 31.0M | 31.0M | 30.7M | 32.0M | 21.5M |
Working Capital Changes | 16.6M | -54.8M | -45.7M | -37.8M | 121.6M |
Operating Cash Flow | 1.3B | 1.2B | 1.1B | 1.2B | 1.7B |
Investing Activities | |||||
Capital Expenditures | - | - | - | - | - |
Acquisitions | -69.8M | -80.5M | -83.7M | -129.3M | -286.8M |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -184.7M | -21.0M | -99.8M | 219.6M | -282.8M |
Financing Activities | |||||
Share Repurchases | - | - | - | -96.0K | -575.0K |
Dividends Paid | -740.3M | -723.6M | -720.3M | -686.9M | -928.8M |
Debt Issuance | 1.9B | 2.5B | 957.8M | 1.5B | 733.3M |
Debt Repayment | -1.6B | -2.0B | -575.4M | -2.1B | -479.5M |
Financing Cash Flow | 1.4B | -545.5M | -292.6M | -566.7M | -1.3B |
Free Cash Flow | 725.8M | 476.9M | 666.1M | 593.1M | 921.5M |
Net Change in Cash | 2.6B | 667.2M | 719.0M | 840.6M | 75.7M |
Cash Flow Trend
Ventas Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
194.30
Forward P/E
400.75
Price to Book
2.52
Price to Sales
5.72
PEG Ratio
400.75
Profitability Ratios
Profit Margin
2.82%
Operating Margin
14.15%
Return on Equity
1.38%
Return on Assets
1.92%
Financial Health
Current Ratio
0.63
Debt to Equity
108.90
Beta
0.97
Per Share Data
EPS (TTM)
$0.33
Book Value per Share
$25.43
Revenue per Share
$12.01
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
vtr | 28.9B | 194.30 | 2.52 | 1.38% | 2.82% | 108.90 |
Welltower | 109.0B | 91.01 | 3.02 | 3.45% | 12.18% | 47.36 |
Omega Healthcare | 12.5B | 25.48 | 2.43 | 10.65% | 42.23% | 96.77 |
Healthpeak | 12.0B | 72.13 | 1.52 | 2.14% | 5.90% | 109.01 |
CareTrust REIT | 7.4B | 27.53 | 2.03 | 8.28% | 58.90% | 34.75 |
American Healthcare | 6.9B | -140.93 | 2.78 | -1.41% | -1.53% | 69.74 |
Financial data is updated regularly. All figures are in the company's reporting currency.